RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Ascend Minocycline 115mg Recall

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA.

Updated June 1, 2026

Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg because some bottles failed to meet dissolution specifications during testing, meaning the medication may not dissolve and release properly in the body.

Is the Ascend Laboratories, LLC recalled? Yes. This product was recalled by FDA on June 1, 2026. Details below.

What is recalled

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, NDC 67877-644-30, manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054. Rx Only.

Am I affected

You're affected if your prescription medication bottle is labeled Minocycline Hydrochloride Extended-Release Tablets, 115 mg, with NDC 67877-644-30, and you received it from Ascend Laboratories.

What to do right now

Contact your pharmacist or doctor to discuss whether your medication is affected and what to do next. Do not stop taking your medication without speaking to your healthcare provider first.

The hazard

Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis

Brands affected

Ascend Laboratories, LLC
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0597-2026
Classification
Class II
Recalled
June 1, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls